邮寄外展邀请可显著提高肝硬化患者的肝细胞癌监测率:一项随机临床试验
该实用随机临床试验纳入1800例肝硬化患者,比较邮寄外展邀请、外展加患者导航与常规诊疗对肝细胞癌监测率的影响。结果显示外展加导航组监测率23.3%、仅外展组17.8%、常规诊疗组7.3%,外展组均显著高于常规诊疗组。
要点
- 邮寄外展邀请联合患者导航使肝细胞癌监测率较常规诊疗提高16.0%(95%CI:12.0%-20.0%)。
- 仅邮寄外展邀请使监测率较常规诊疗提高10.5%(95%CI:6.8%-14.2%)。
- 外展加导航较仅外展提高5.5%(95%CI:0.9%-10.1%)。
核心结论
- 在肝硬化患者中,邮寄外展邀请和患者导航较常规诊疗显著提高肝细胞癌监测率。
研究设计与样本
- 实用随机临床试验,在大型安全网医疗系统纳入1800例肝硬化患者,2014年12月至2017年3月进行。
- 患者随机分为邮寄外展邀请行筛查超声组(n=600)、邮寄外展邀请加患者导航组(n=600)或常规诊疗随诊筛查组(n=600)。
- 未在2周内回应外展邀请的患者接受提醒电话;患者导航包括评估监测障碍并鼓励参与监测。
- 主要结局为18个月期间的肝细胞癌监测(每6个月腹部影像检查),全部1800例纳入意向筛查分析。
主要发现
- 肝细胞癌监测率:外展加导航组23.3%,仅外展组17.8%,常规诊疗组7.3%。
- 外展组较常规诊疗组监测率提高16.0%(95%CI:12.0%-20.0%)和10.5%(95%CI:6.8%-14.2%),均P<0.001。
- 外展加导航组较仅外展组监测率提高5.5%(95%CI:0.9%-10.1%),P=0.02。
- 两种干预在预设患者亚组中均提高肝细胞癌监测率。
- 早期肝细胞癌检出比例组间无差异;筛查发现的肝细胞癌患者中早期肿瘤比例高于偶然或症状发现的肝细胞癌患者(83.3% vs 30.8%,P=0.003)。
临床怎么用
- 原文结论为邮寄外展邀请和患者导航较常规诊疗显著提高肝硬化患者的肝细胞癌监测率。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Hepatocellular carcinoma (HCC) surveillance is associated with early tumor detection and improved survival in patients with cirrhosis; however, effectiveness is limited by underuse. We compared the effectiveness of mailed outreach and patient navigation strategies to increase HCC surveillance in a racially diverse cohort of patients with cirrhosis. We conducted a pragmatic randomized clinical trial comparing mailed outreach for screening ultrasound (n = 600), mailed outreach plus patient navigation (n = 600), or usual care with visit-based screening (n = 600) among 1800 patients with cirrhosis at a large safety-net health system from December 2014 to March 2017. Patients who did not respond to outreach invitations within 2 weeks received reminder telephone calls. Patient navigation included an assessment of barriers to surveillance and encouragement of surveillance participation. The primary outcome was HCC surveillance (abdominal imaging every 6 months) over an 18-month period. All 1800 patients were included in intention-to-screen analyses. HCC surveillance was performed in 23.3% of outreach/navigation patients, 17.8% of outreach-alone patients, and 7.3% of usual care patients. HCC surveillance was 16.0% (95% confidence interval [CI]: 12.0%-20.0%) and 10.5% (95% CI: 6.8%-14.2%) higher in outreach groups than usual care (P < 0.001 for both) and 5.5% (95% CI: 0.9%-10.1%) higher for outreach/navigation than outreach alone (P = 0.02). Both interventions increased HCC surveillance across predefined patient subgroups. The proportion of HCC patients detected at an early stage did not differ between groups; however, a higher proportion of patients with screen-detected HCC across groups had early-stage tumors than those with HCC detected incidentally or symptomatically (83.3% versus 30.8%, P = 0.003). Conclusion: Mailed outreach invitations and navigation significantly increased HCC surveillance versus usual care in patients with cirrhosis.
引用
- Singal AG, Tiro JA, Murphy CC, et al. Mailed Outreach Invitations Significantly Improve HCC Surveillance Rates in Patients With Cirrhosis: A Randomized Clinical Trial. Hepatology. 2018. PMID: 30070379. doi:10.1002/hep.30129
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。